Alpha Cognition Research and Development Expenses 2020-2024 | ACOG
Alpha Cognition research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Alpha Cognition Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$5 |
| 2022 |
$9 |
| 2021 |
$8 |
| 2020 |
$5 |
| 2019 |
$4 |
Alpha Cognition Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-06-30 |
$1 |
| 2024-03-31 |
$1 |
| 2023-12-31 |
$1 |
| 2023-09-30 |
$1 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$1 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$3 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$2 |
| 2020-12-31 |
$1 |
| 2020-09-30 |
$1 |
| 2020-06-30 |
$2 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
